China Health Industries Holdings, Inc. Stock Other OTC
Equities
CHHE
US1693981045
Pharmaceuticals
Financials (USD)
Sales 2022 | 267 | Sales 2023 | 112K | Capitalization | 14.66M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | -139,809 x |
Net cash position 2022 | 38.03M | Net Debt 2023 | 5.11M | EV / Sales 2023 | 177 x |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-35.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.71% |
Managers | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Melody Zhang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |